ICH Project ICH Japan Symposium 2010

December 22, 2010

ICH Japan Symposium 2010 (23rd ICH Public Meeting)
ICH Public Meeting: ICH Japan Symposium 2010


As a forum for presenting and discussing the outcomes of the ICH Fukuoka Meeting (November 6–11, 2010, Fukuoka City), the third ICH Regional Meeting in the Japan region, titled “ICH Japan Symposium 2010,” was held on December 2, 2010, at Tsuda Hall in Tokyo.

The symposium was held according to the following program. First, in Part I, presentations and discussions were held on the progress and outcomes of the expert working groups at the Fukuoka Conference, covering trends in various topics. In Part II, a special session was held as a comprehensive discussion on pharmacovigilance, with the participation of experts from both the industry and regulatory sectors.During this session, a comprehensive discussion was held regarding the E2-related guidelines (E2A, E2B, E2D, E2E, E2F), including the E2C Periodic Safety Update Report (PSUR) for over-the-counter drugs, covering gaps between regions and between guidelines.

The program, presentation schedule, and presentation materials for this symposium are attached below and can be viewed directly.

Please note that the presentation materials titled “Trends in Quality-Related Topics: Q-IWG Quality Implementation Working Group” are available for viewing at the ICH Q8, Q9, and Q10 Guidelines Practical Training Workshop.

Please note that unauthorized copying or reproduction of the attached materials is prohibited.

Date, Time, and Venue

Date and Time Location
Thursday, December 2, 2010, 10:00 a.m.–4:40 p.m. Tsuda Hall
, 1-18-24 Sendagaya, Shibuya-ku, Tokyo

Information and Program

Presentation Materials

You can scroll horizontally

Presentation Speaker
00_Opening Remarks (42KB) Kohei Wada (Daiichi Sankyo)
Part I: Trends in the Topic 01_The History of ICH (533KB) Riko Suzuki (Ministry of Health, Labor and Welfare)
02_Latest ICH Developments (255KB) Kurajiro Kishi (JPMA)
Trends in Topics Related to Electronic Standards for the Transmission of Pharmaceutical Regulatory Information 03_M2: Electronic Standardization for the Transmission of Pharmaceutical Regulatory Information (250KB) Takashi Adachi (Janssen Pharmaceutical)
04_E2B (R3): Data Elements and Message Specifications for Transmitting Individual Case Safety Reports (364KB) Ayumi Endo (NIH)
05_M5: Data Elements and Standards for Pharmaceutical Dictionaries (472KB) Izumi Oba (NIH)
06_M8 (eCTD): Electronic Submission Forms (283 KB) Koji Shomoto (Boehringer Ingelheim Japan)
Trends in Topics Related to Efficacy 07_E2C (R2): Periodic Post-Marketing Safety Reports (178KB) Tomoko Okuhira (NIH)
08_E14 IWG: Clinical Evaluation of QT Prolongation and Serious Arrhythmias (154KB) Maki Ito (Shionogi & Co., Ltd.)
Trends in Safety-Related Topics 09_S6 (R1): Nonclinical Safety Evaluation of Biopharmaceuticals (Revision) (297 KB) Kazuto Watanabe (Chugai Pharmaceutical)
10_S10: Phototoxicity Testing (333KB) Hiroshi Nakae (Tokyo Metropolitan Institute of Public Health)
11_M3 (R2) IWG: Timing of Nonclinical Studies (169KB) Fumio Sakami (Eisai)
12_M6, GTDG: Virus/Vector Shedding and Transmission, Gene Therapy Drug Discussion Group (606KB) Wataru Toriumi (POC Clinical Research)
13_M7: Evaluation and Control of DNA-Reactive Impurities (869KB) Masamitsu Honma (National Institute of Health Sciences)
Trends in Quality-Related Topics 14_Q3D: Metallic Impurities (109 KB) Masayuki Mishima (Chugai Pharmaceutical)
15_Q4B: Evaluation and Recommendations for the Mutual Use of Pharmacopoeia Texts in ICH Regions (244 KB) Masaaki Wada (Shionogi & Co., Ltd.)
16_Q11: Development and Manufacturing of Active Pharmaceutical Ingredients for Chemical and Biopharmaceuticals (165KB) Kazunori Takagi (NIH)
17_Q-IWG: Quality Implementation Working Group (139KB) Yoshihiro Matsuda (NIH)
Part II: Special Session on Pharmacovigilance 18_PV Panel 1: Summary (376KB) Daisaku Sato (Ministry of Health, Labour and Welfare)
19_PV Panel 2: Industry Perspective (173KB) Yoko Hattori (Daiichi Sankyo)
20_PV Panel 3: Government Perspective (133KB) Tomoko Okuhira (NIH)
 

Share this page

TOP